Tag Archives: mRNA dangerous

Sep 15 2023

South Korea to Pay Families of COVID Vax Victims


Armstrong Economics Blog/Disease Re-Posted Sep 15, 2023 by Martin Armstrong

Various governments are quietly acknowledging the dangers of the COVID-19 experimental mRNA vaccines. The Korea Disease Control and Prevention Agency announced that families are entitled to compensation if their relative dies within 90 days of receiving the vaccine. The max one can receive is 30 million won or $22,500 – a strange price to put on a person’s life.

They are not even requiring an autopsy if that is any indication of how dangerous these vaccines have been. They are also providing additional government aid for families who had a relative die within THREE days of the untested experimental jab. “Korea had a higher inoculation rate than the rest of the world because people trusted the state and got vaccinated,” People Power Party Rep. Park Dae-chul stated at a National Assembly meeting between the party and the administration. “In this regard, the state must address the blind spot in helping those harmed by the vaccination policy.”

Yes, the state should be held responsible for coercing people into a lethal medical decision. This was not the government’s first choice, as the Seoul Administrative Court demanded that the KDCA compensate families. There are also 11 different medical side effects, such as myocarditis, pericarditis, and anaphylaxis that the government admits are a result of the vaccine. Over 480 million won has been distributed so far. The government recognizes 15 additional ailments caused by the vaccine, such as Bell’s Palsy, but will not compensate individuals for those side effects.

South Korea has begun paying burial fees for those who died from the COVID vaccine. The government forced 45 million men, women, and children into receiving these vaccines. So why in the world would South Korea continue to provide COVID vaccines at all? Rest assured Big Pharma is not making any payouts for deaths or irreparable harm.

Sep 12 2023

FDA Approves COVID Election Booster to Begin Immediately


Posted originally on the CTH on September 11, 2023 | Sundance 

As expected, the FDA has approved a new series of COVID-19 “booster” vaccines which are immediately available for anyone who trusts the institutions of government to be focused on your health and wellbeing.   For everyone else, hard pass.

“The FDA is confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.”

FDA – Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Consistent with the totality of the evidence and input from the FDA’s expert advisors, these vaccines have been updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5.

What You Need to Know

• Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.

• Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).

• Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated authorized Moderna COVID-19 Vaccine.

• The FDA is confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.

• Individuals who receive an updated mRNA COVID-19 vaccine may experience similar side effects as those reported by individuals who previously received mRNA COVID-19 vaccines as described in the respective prescribing information or fact sheets.

• The updated vaccines are expected to provide good protection against COVID-19 from the currently circulating variants. Barring the emergence of a markedly more virulent variant, the FDA anticipates that the composition of COVID-19 vaccines may need to be updated annually, as is done for the seasonal influenza vaccine.

• The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet tomorrow (Sept. 12), to discuss clinical recommendations on who should receive an updated vaccine, as well as further considerations for specific populations such as immunocompromised and older individuals.

• Manufacturers have publicly announced that the updated vaccines would be ready this fall, and the FDA anticipates that the updated vaccines will be available in the near future. (read more)